Stories written by

Filipa Henderson Sousa, The Conversation

WHO has added two new drugs to its Covid-19 treatment guidelines. Here’s how they work

Sotrovimab and baricitinib target Covid-19 at different stages of its development, and will give doctors greater flexibility in treating Omicron patients.

Filipa Henderson Sousa, The Conversation
· Feb 03, 2022 · 09:30 pm
A new oral antiviral drug for Covid-19 is moving into the final stages of testing in humans

In an initial trial, molnupiravir had successfully reduced the ability of SARS-CoV-2 to replicate.

Filipa Henderson Sousa, The Conversation
&
Peter Barlow, The Conversation
· Oct 07, 2021 · 07:30 pm